Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels by controlling ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases.

Register for Details

For more details on financing and valuation for Nurix, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Nurix's ticker symbol?


What is Nurix's stock price?

8.84 as of 3/24/23

Learn more about Nurix

Forge green plus iconForge green minus icon

What is Nurix funding to date?

Nurix has raised $48.38MM.
Forge green plus iconForge green minus icon

When was Nurix founded?

Nurix was founded in 2012.